LYELL Trademark

Trademark Overview


On Tuesday, May 4, 2021, a trademark application was filed for LYELL with the United States Patent and Trademark Office. The USPTO has given the LYELL trademark a serial number of 90689670. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, October 30, 2023. This trademark is owned by Lyell Immunopharma, Inc.. The LYELL trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Custom manufacture of pharmaceuticals

Pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; cells for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposes

Medical services; medical services, namely, medical services utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; medical services for treatment of cancer

Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; scientific laboratory services; medical and scientific research; scientific and technological services and biological research and development relating thereto, namely, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; scientific and technological services and biological research and development, namely, research and development related to treatment of cancer
lyell

General Information


Serial Number90689670
Word MarkLYELL
Filing DateTuesday, May 4, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, October 30, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements


Goods and ServicesCustom manufacture of pharmaceuticals
Description of MarkThe mark consists of the word "Lyell" surrounded by three incomplete circles each of which has an opening at the right.
Goods and ServicesPharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; cells for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposes
Goods and ServicesMedical services; medical services, namely, medical services utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; medical services for treatment of cancer
Goods and ServicesPharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; scientific laboratory services; medical and scientific research; scientific and technological services and biological research and development relating thereto, namely, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; scientific and technological services and biological research and development, namely, research and development related to treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, August 6, 2021
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 6, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 6, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLyell Immunopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameLyell Immunopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Wednesday, November 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 30, 2023SOU EXTENSION 3 GRANTED
Monday, October 30, 2023SOU EXTENSION 3 FILED
Monday, October 30, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 14, 2023SOU EXTENSION 2 GRANTED
Friday, April 14, 2023SOU EXTENSION 2 FILED
Friday, April 14, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 14, 2022SOU EXTENSION 1 GRANTED
Friday, October 14, 2022SOU EXTENSION 1 FILED
Friday, October 14, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 3, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 14, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 14, 2021NON-FINAL ACTION E-MAILED
Thursday, October 14, 2021NON-FINAL ACTION WRITTEN
Wednesday, October 13, 2021ASSIGNED TO EXAMINER
Friday, October 1, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 1, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 1, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, August 7, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, August 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 7, 2021NEW APPLICATION ENTERED